NHS Improvement Hospital Pharmacy and Medicines Optimisation

Slides:



Advertisements
Similar presentations
Community Pharmacy – Call to Action Derbyshire / Nottinghamshire Area Team.
Advertisements

NOW OR NEVER: SHAPING PHARMACY FOR THE FUTURE
Ian Williamson Chief Officer Greater Manchester Health and Social Care Devolution NW Finance Directors Friday 15 May 2015 Ian Williams Chief Officer Greater.
Chairman, Pharmaceutical Market Support Group
Commission on Education & Training for Patient Safety.
1. How can we promote pharmacies and the full service available? Think about: How the NHS works with Local Authorities to enhance the role of community.
The Medicines use and Procurement QIPP Programme PDIG June 2012 Clare Howard National Lead for QIPP Medicines use and Procurement.
Andrew Alldred Clinical Director / Director of Pharmacy Harrogate NHS FT Chair – National Pharmaceutical Supply Group November 2011.
Should we receive professional procurement training? Matt Condon Pharmacy Procurement Manager PDIG Autumn Symposium Thursday, 11 th November 2010.
October 2011 COMMISSIONING DEVELOPMENT PROGRAMME – WORK IN PROGRESS Health and well being boards Clinical Commissioning Groups Strategy, policy, contract,
PROCUREMENT & DISTRIBUTION INTEREST GROUP Autumn Symposium 2007
Wessex LETB The Changing Landscape Paul Holmes, Managing Director.
Medicines Optimisation Presented by Sue Mulvenna Pharmacist Lead SW Strategic Clinical Networks November 2014.
A Hospital without a Pharmacy - building a first class pharmacy service Anne Cope Associate Director of Pharmacy University Hospital Birmingham NHS Foundation.
Community Pharmacy in 2016 and beyond: A summary of the Pharmacy Voice response Nanette Kerr Chief Executive Officer Company Chemists’ Association A member.
November 2012 Engaging with Better Training Better Care - Heather Penny.
What does the cancer landscape look like now? - The national context for cancer intelligence Jason Poole, Deputy Head (Local Interface), National Cancer.
Briefing Presentation – February 2010 Service line management proposals.
Staffing matters; funding counts Workforce profile and trends in the English NHS July 2016.
7 September 2016 DH – Leading the nation’s health and care
NHS England High Cost Drug Minimum Dataset (MDS)
Quality, Safety and Value
Karen Harrowing – Senior Associate
HEALTH DEVOLUTION: WHAT SHOULD PUBLIC AND PATIENT INVOLVEMENT LOOK LIKE DURING THIS ERA OF HEALTH AND SOCIAL CARE TRANSFORMATION Presentation to the All.
Knowledge for Healthcare: Driver Diagrams October 2016
Implementing the NHS dictionary of medicines and devices (dm+d)
Disclosure UK Talking about Transparency.
Template LPC stakeholder map
Update re Safe Staffing September 2016
The Future Operating Model for NHS procurement
Commissioners, Providers and Sustainable Development
HEE Nursing Associate Programme
Raising standards, putting people first
National Immunoglobulin Database Meeting Procurement Update
Digital Medicines Hospital Pharmacy Transformation Programme.
Information Sharing for Integrated care A 5 Step Blueprint
Technology Enabled Care Services in Nottingham City
Nottinghamshire & Derbyshire GP / Pharmacy Transformation Programme Unlocking the Potential of Community Pharmacy Cathy Quinn Pharmacist Lead Newark &
All England Pharmacy Fellows Network
The National Data Guardian review & Government response
Hospital pharmacy transformation plans – digital content
Integrating Clinical Pharmacy into a wider health economy
Medicines Optimisation Closed Loop Medicines Management & Scan4Safety
Disclosure UK Talking about Transparency.
Patient Safety Guidance- development, implementation and compliance
Preventing VTE in hospitalised patients
What is the HCS NDP? The structure of how we are aligning Test Of Changes to the NDP and overhaul national strategy - Should we have anything else on the.
EoLc in Gloucestershire
Update to NLAG board 24th November 2015
The Community Pharmacy Forward View Aug 2016
CQC: The new approach to inspection
The ‘New’ NHS – The Challenges for Children’s Service
Integrated Care System (ICS) Berkshire West
Mental Health Action Group
So you’ve been inspected…. communicators driving improvement
Medicines Safety Programme
Implementing Sustainable Systems - Health and Care
Gloucestershire Redesign of Urgent and Emergency Care
Author: Beke Tshuma Implementation Lead – Older Person’s Care
Key Drivers Carter 1 report recommendations based around efficiency and productivity Carter 2 report: Recommendation 11 – Medicines and Pharmacy Optimisation.
Well Connected Programme Enabling Projects
Equality and Diversity Council
01/05/2019 Consultancy Business Intelligence Insight and Analysis CoP Specialty Skills 1.
Safe, high quality care for all – the importance of accreditation
Patient Safety Guidance- development, implementation and compliance
NHS England Biosimilar Implementation Steve Brown Regional Pharmacist, NHS England / NHS Improvement, South West and South East England AWTTC Biosimilar.
Patient Group Directions
The National Data Guardian review & Government response
South Yorkshire and Bassetlaw Integrated Care System
Pharmacy Integration Improving care in care homes
Presentation transcript:

NHS Improvement Hospital Pharmacy and Medicines Optimisation Ann Jacklin, November2016 Title slide with embedded images

Timeline Summer 2014 June 2015 February 2016 Health Secretary asks Lord Carter to assess what efficiency improvements could be generated in hospitals across England Detailed work with 22 NHS acute hospital trusts initially – range of trust types from large inner city teaching to rural district general hospitals Hospital Pharmacy and Medicines Optimisation Programme (HoPMOP) established June 2015 Interim report published Up to £5 billion of productivity saving identified Concept of Model Hospital February 2016 Final report published “In light of Lord Carter’s report, I can now announce that we will act upon all his recommendations and have asked Lord Carter to report back on progress with implementation by spring 2017”

Report recommendations Values & outcomes from Medicines Optimise medicines (and staff…..) Hospital Pharmacy Transformation Plan by April 2017 Clinical Pharmacy Infrastructure services Model Hospital metrics

Hospital Pharmacy Transformation Programme HPTP 80% pharmacist time on CLINICAL activity EPMA High Cost Drugs coding Drug savings Drug Procurement - CMU Supply chain Specialised Pharmacy Service NHS Manufactured Medicines Catalogue

Transforming clinical and infrastructure services Currently 45% of time Currently 55% of time

Clinical Pharmacy Services Lord Carter said: Acute trusts must ensure their pharmacists and clinical pharmacy technicians spend much more time on clinical pharmacy services than on infrastructure activities He also said: …more clinical pharmacy staff…..deployed…..working more closely…..with patients, doctors , nurses and independently…. To deliver optimal use of medicines……informed medicines choices….secure better value…..drive better outcomes…..contribute to 7 day services…. He didn’t say: Current clinical services meet needs either in volume or in ‘scope’

Pharmacy Infrastructure services Lord Carter said: Are subject to stark variation Can be delivered more efficiently ..are most efficiently delivered…..through..…collaboration or shared service…..local, regional, national Need not be delivered by NHS employed staff Lord Carter didn’t say: Are not valued Are not essential Are not required Don’t require expertise

HPTP governance arrangements (proposed) HPTP Programme Board NHSI Programme Management & Delivery Team Professional lead Subject matter experts Programme Support Infrastructure Projects Model Hospital & Metrics Project All MH Recommendations Stakeholders involved: NHS trusts NHSI CQC HSCIC MH stakeholders Pharmacy system suppliers All infrastructure Recommendations Stakeholders involved: DH/MPI/CMU NHSE SPS National Information Board (for Meds Digital Strategy) GS1 & Peppol HDA (BAPW) Programme Management Office & Data Analyst support Chief Pharmaceutical Officer (SRO) NHSI Pharmacy Lead NHSI Region 1 NHSI Region 3 NHSI Region 2 NHSI Region 4 All MO Recommendations. Stakeholders involved: NHS E MO NHS E SPS HEE RPS ABPI/BGMA Medicines Optimisation Project

Trade bodies & suppliers HPTP Landscape HPTP NHS Improvement Carter Implementation role NHS England Right Care Specialised commissioning SPS Meds Optimisation RMOC Trade bodies & suppliers ABPI BGMA HAD PMSG NPSG CMU NHS Information Board DM&D FMD Scan for safety 136 NHS acute trusts Workforce HEE CPPE Metrics MH Hospital CQC NHS Benchmarking Professional bodies RPS APTUK GPhC Dept of Health 7 day services MPI Rebalancing

Making it business as usual Failure Success

HPTP timeline